Different Types of Pet Radiation Treatment
Stereotactic Radiation Therapy (SRT)
Stereotactic radiation therapy, also known as SRT, uses focused radiation beams to target tumors with unprecedented precision. Because of this accuracy, normal surrounding tissue is mostly spared, minimizing damage to healthy areas and decreasing potential side effects.
SRT is used to treat tumors that would otherwise be considered inoperable or untreatable through traditional radiation therapy. It can target the brain, nasal, prostate tumors, mast cell tumors, osteosarcomas, and tumors located near vital organs.
Stereotactic radiation therapy offers the shortest treatment schedule. The entire radiation dose can be delivered in 1 to 3 sessions lasting less than 15 minutes each and is usually completed within just one week. This greatly reduces the number of times a patient must undergo anesthesia, while also providing added efficiency and convenience for the pet’s caregivers.
Image-Guided Radiation Therapy (IGRT)
Image-guided radiation therapy (IGRT) is one of the most important innovations in cancer treatment. The slightest body movement, such as breathing, can cause the targeted tumor to move. IGRT allows for precise location mapping, tracking and treatment delivery.
Strontium-90 Plesiotherapy
Strontium–90 Plesiotherapy is used to treat superficial (surface–level) tumors of the skin, including eyelids and ears, many of which are difficult to remove surgically. The dime–sized radioactive probe delivers low energy radiation that only travels about 4mm deep, avoiding any underlying body systems while effectively treating the tumor.
Treatment is usually completed in one or two 5–10–minute sessions, and side effects are rare due to the low penetration level of the radiation.
Palliative Radiation Therapy
The goal of palliative radiation therapy is not to cure the pet’s disease, but to improve their quality of life by reducing the pain and swelling that accompanies some tumors.
Treatments are typically given 1–6 times per week over 1–6 weeks. Not all pets benefit from palliative care, but those who do can start to experience improvements within days of the first dose. Benefits often last 2–4 months or longer and can be repeated for most patients when symptoms of the cancer return.
Definitive Radiation Therapy
When surgery is not performed prior to radiation treatment, it is called definitive radiation therapy. This approach to treatment is typically used when a tumor cannot be surgically removed without great risk or complications for the pet, like those inside the nasal passage, perineum and brain, and some soft tissue sarcomas.
Because the radiation passes through normal tissue surrounding the tumor, multiple small doses of radiation are given to maximize the damage to the abnormal cancerous tissue while minimizing the damage to the surrounding normal tissue.
Definitive radiation treatments are typically given over 5 consecutive days or twice a week for 3-4 weeks.
Conventional Radiation Therapy
Conventionally fractionated radiation therapy (CFRT) uses targeted radiation to shrink or destroy cancers that cannot be safely or completely removed by surgery alone. It can also be utilized in conjunction with, or in place of, chemotherapy, or delivered following surgery if the initial procedure is unable to completely remove cancer. CFRT is typically administered in 15–21 treatment sessions over 3–7 weeks. Pets will need to be anesthetized to ensure they remain still during each session.
Intensity-Modulated Radiation Therapy (IMRT)
Like conventional radiation therapy, IMRT uses multiple doses of small increments of high-energy x-rays to target a tumor, and is also usually given on a daily Monday through Friday schedule over a period of 3 weeks to 1 month. Like SRS and SBRT, IMRT is another complex and precise method of delivering radiation therapy that relies on detailed imaging and computerized three-dimensional treatment planning to obtain the accuracy needed to minimize radiation side effects.
Due to its precision, IMRT spares the surrounding normal tissue and is beneficial for tumors in the nasal cavity or regions where radiosensitive structures need to be avoided. The radiation oncologist determines if IMRT would be more beneficial than conventional radiation therapy or stereotactic radiation therapy.